Patricia A. Hogan

TL;DR: Prevalence of MRSA among both inpatient and outpatient specimens continues to increase with multi-drug resistance as a common phenotype, which has important implications for developing and evolving outpatient treatment guidelines.

TL;DR: The analysis of baseline-to-end point change in the percentage of susceptibility and the slope of the regression line (trend line) for logit percentage of susceptible showed that the overall percentage of vulnerability to fluoroquinolones decreased significantly during the study period.

TL;DR: Findings indicate that linezolid nonsusceptibility has remained rare among staphylococci and uncommon and sporadic among enterococci, and careful and ongoing monitoring of the in vitro effectiveness oflinezolid will be needed so that any changes to the current status may be detected as soon as possible.

TL;DR: Linezolid demonstrated excellent activity and a sustained susceptibility rate of 99.78% overall in the linezolid-nonsusceptible MRSA strains evaluated.

TL;DR: This surveillance report documents stable linezolid activity and susceptibility rates against a large and longitudinal collection of clinical isolates worldwide.